{"id":10562,"date":"2016-09-28T00:00:00","date_gmt":"2016-09-27T22:00:00","guid":{"rendered":"https:\/\/idibell.cat\/es\/blog\/2016\/09\/28\/idibell-presenta-su-portafolio-tecnologico-en-biospain-2016\/"},"modified":"2020-05-20T10:00:15","modified_gmt":"2020-05-20T08:00:15","slug":"idibell-presenta-su-portafolio-tecnologico-en-biospain-2016","status":"publish","type":"post","link":"https:\/\/idibell.cat\/es\/2016\/09\/idibell-presenta-su-portafolio-tecnologico-en-biospain-2016\/","title":{"rendered":"IDIBELL presenta su portafolio tecnol\u00f3gico en Biospain 2016"},"content":{"rendered":"<p><strong>Desde hoy y hasta este viernes, la unidad de desarrollo de negocio e innovaci\u00f3n del IDIBELL participa en la octava edici\u00f3n de<\/strong><strong><b><br \/><\/strong><strong><a href=\"http:\/\/www.biospain2016.org\/\">Biospain 2016<\/a>,<b><br \/>la cita biotecnol\u00f3gica m\u00e1s importante del sur de Europa<\/strong> Miembros del area de Desarrollo de Negocio e Innovaci\u00f3n del Instituto de Investigaci\u00f3n Biom\u00e9dica de Bellvitge (IDIBELL) se han desplazado al Bilbao Exhibition Center (BEC) de Barakaldo para participar en el 8\u00ba congreso Biospain, la 5\u00aa reuni\u00f3n biotecnol\u00f3gica en el ranking mundial por n\u00famero de reuniones de partenariado. En esta edici\u00f3n est\u00e1n previstos 2.000 asistentes, 855 compa\u00f1\u00edas y cerca de 50 inversores. <b><br \/> \u201cVenimos a Biospain con un objetivo claro en mente, fomentar el establecimiento de colaboraciones con la industria ya sea a trav\u00e9s de licencias, proyectos co-desarrollados o spin-offs biotecnol\u00f3gicas\u00bb, explica Raquel Egea, directora del \u00e1rea de desarrollo de negocio e innovaci\u00f3n del IDIBELL. \u00abPara lograrlo, nos presentamos con un portafolio tecnol\u00f3gico de 13 proyectos puestos en marcha en el IDIBELL que creemos que pueden encajar muy bien con las estrategias de los inversores y compa\u00f1\u00edas presentes en la feria\u00bb. <b><br \/> Entre los proyectos de investigaci\u00f3n en biomedicina que el IDIBELL presenta en BioSpain, se pueden encontrar innovaciones para el diagn\u00f3stico y pron\u00f3stico de diferentes enfermedades como Alzheimer, accidente cardiovascular isqu\u00e9mico, fertilidad y diferentes tipos de c\u00e1ncer; terapias relacionadas con respuestas del sistema inmune y con el c\u00e1ncer; f\u00e1rmacos para diferentes tipos de enfermedades; dispositivo m\u00e9dico para cirug\u00eda digestiva; y software para rehabilitaci\u00f3n de par\u00e1lisis faciales. <b><br \/> Biospain 2016 tiene lugar en el marco de la<b><br \/><a href=\"http:\/\/www.biotechweek.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">European Biotech Week<\/a>,<b><br \/>del 26 de septiembre al 2 de octubre, y ser\u00e1 uno de los eventos m\u00e1s importantes en Europa durante esta semana. En la \u00faltima edici\u00f3n, celebrada en Santiago de Compostela en 2014, Biospain cont\u00f3 con 200 expositores, 2000 asistentes<b><br \/>y 855 empresas e instituciones procedentes de 37 pa\u00edses, se llevaron a cabo 3.327<b><br \/>reuniones <em>one-to-one y<b><br \/><\/em>50 conferencias cient\u00edficas y se presentaron 720 productos<b><br \/>para ser licenciados.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Desde hoy y hasta este viernes, la unidad de desarrollo de negocio e innovaci\u00f3n del IDIBELL participa en la octava edici\u00f3n de  Biospain 2016,\u00a0la cita biotecnol\u00f3gica m\u00e1s importante del sur de Europa<\/p>\n","protected":false},"author":6,"featured_media":10563,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[123],"class_list":["post-10562","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categorizar","tag-promocion"],"publishpress_future_action":{"enabled":false,"date":"2024-11-29 16:27:34","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/10562","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=10562"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/10562\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media\/10563"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=10562"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/categories?post=10562"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/tags?post=10562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}